211 related articles for article (PubMed ID: 29797655)
1. Hepatitis C genotype change after transplantation utilizing hepatitis C positive donor organs.
Adekunle R; Jonchhe S; Ravichandran B; Wilson E; Husson J
Transpl Infect Dis; 2018 Aug; 20(4):e12925. PubMed ID: 29797655
[TBL] [Abstract][Full Text] [Related]
2. Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?
Selzner N; Berenguer M
Liver Transpl; 2018 Jun; 24(6):831-840. PubMed ID: 29624894
[TBL] [Abstract][Full Text] [Related]
3. Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.
Saberi B; Hamilton JP; Durand CM; Li Z; Philosophe B; Cameron AM; Sulkowski MS; Gurakar A
Liver Transpl; 2018 Jan; 24(1):140-143. PubMed ID: 28779557
[No Abstract] [Full Text] [Related]
4. Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients.
Ting PS; Hamilton JP; Gurakar A; Urrunaga NH; Ma M; Glorioso J; King E; Toman LP; Wesson R; Garonzik-Wang J; Ottmann S; Philosophe B; Sulkowski M; Cameron AM; Durand CM; Chen PH
Transpl Infect Dis; 2019 Dec; 21(6):e13194. PubMed ID: 31609520
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
[TBL] [Abstract][Full Text] [Related]
6. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
[TBL] [Abstract][Full Text] [Related]
7. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
[TBL] [Abstract][Full Text] [Related]
8. Maximizing donors with viral hepatitis in the current era.
Brown K
Liver Transpl; 2017 Oct; 23(S1):S44-S49. PubMed ID: 28846183
[No Abstract] [Full Text] [Related]
9. Temporal Changes and Regional Variation in Acceptance of Hepatitis C Virus-Viremic Livers.
Mazur RD; Goldberg DS
Liver Transpl; 2019 Dec; 25(12):1800-1810. PubMed ID: 31539195
[TBL] [Abstract][Full Text] [Related]
10. Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.
Rupp C; Hippchen T; Neuberger M; Sauer P; Pfeiffenberger J; Stremmel W; Gotthardt DN; Mehrabi A; Weiss KH
World J Gastroenterol; 2018 Mar; 24(12):1353-1360. PubMed ID: 29599610
[TBL] [Abstract][Full Text] [Related]
11. Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection.
Weiler N; Zeuzem S; Welker MW
World J Gastroenterol; 2016 Nov; 22(41):9044-9056. PubMed ID: 27895394
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
[TBL] [Abstract][Full Text] [Related]
14. Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.
Kasarala G; Choi S; Lopez K; Britt RB; Boatright C; Tillmann HL
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29064152
[No Abstract] [Full Text] [Related]
15. Functional Behavior of NKp46-Positive Intrahepatic Natural Killer Cells Against Hepatitis C Virus Reinfection After Liver Transplantation.
Tanimine N; Tanaka Y; Abe T; Piao J; Chayama K; Ohdan H
Transplantation; 2016 Feb; 100(2):355-64. PubMed ID: 26714120
[TBL] [Abstract][Full Text] [Related]
16. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
[TBL] [Abstract][Full Text] [Related]
17. New insights into the rational use of HCV+ organs worldwide.
Morales JM; Sawinski D
Clin Transplant; 2019 Dec; 33(12):e13739. PubMed ID: 31648391
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation.
Khaderi S; Shepherd R; Goss JA; Leung DH
World J Gastroenterol; 2014 Aug; 20(32):11281-6. PubMed ID: 25170212
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation from anti-hepatitis C virus-positive donors: our experience.
Álvaro E; Abradelo M; Fuertes A; Manrique A; Colina F; Alegre C; Calvo J; García M; García-Sesma A; Cambra F; Sanabria R; Moreno E; Jimenez C
Transplant Proc; 2012; 44(6):1475-8. PubMed ID: 22841188
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.
Bari K; Luckett K; Kaiser T; Diwan T; Cuffy M; Schoech MR; Safdar K; Blackard JT; Apewokin S; Paterno F; Sherman KE; Zucker SD; Anwar N; Shah SA
Hepatology; 2018 May; 67(5):1673-1682. PubMed ID: 29205441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
